GLG News by Physicians who Perform Dialysis

1)  Baxter was producing 50% of the worlds heparin requirements, which provided short term anticoagulation for hemodialysis and various interventions for cardiovascular disease. 2)  The base product of heparin comes from porcine intestines. 3)  The base product of Baxter's heparin was...

1)  Amgen's and J&J's ESA products are going to continue to receive more black box warnings from the FDA. 2)  A federal Judge may force Amgen to accept a royalty from Roche, allowing their CERA ESA to come to market in the USA. 3)  Their is potential for more problems to arise,...

Although patient deaths are of grave concern, the impact of a heparin shortage stand to put around 400,000 US dialysis patients at risk.  Heparin is the "oil of hemodialysis" and without it, hemodialysis would come to a standstill. There are alternatives available, such as Andiomax and Lovenox,...

Ferumoxytol is not likely to gain market share and widespread use by hemodialysis centers.  This new iron preparation offers no benefit over Ferrlecit and Venofer.  Additionally, hemodialysis patient's are not inconvenienced by 30 minute infusion versus a 5-minute infusion.

Many of the novel esa's were in development prior to the choir study results and FDA black box label.  They probably would have thought twice about investment into an agent that has a main selling point of "long half-life".  This implies that he could potentially be more difficult to titrate...

This drug is from a new class of agents that treat type II diabetes. The advantages of this class of drugs is that there is no hypoglycemia nor is there weight gain on those patients being treated with them.